Our Blog | Biosimilars & Generics | AAM

Jan 9, 2020 | Karin Hessler

Competition Matters. That’s Why We Need to Further Improve IPR.

Dec 18, 2019 | Kristin Murphy

Women-Powered Health Policy: 500 and Counting

Nov 19, 2019 | Jonathan Kimball

Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA

Nov 18, 2019 | Erica Klinger

Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner

Nov 14, 2019 | Erica Klinger

How Our Associate Members Make the World Healthier

GRx+Biosims Day 3 Healthcare Innovation and The Political Economy

Nov 11, 2019 | Erica Klinger

GRx+Biosims Year 2: The Recap

Generic Rx World Manufacturing

Oct 29, 2019 | Rachel Schwartz

AAM Testimony on the Generic Global Supply Chain—Five Takeaways

Oct 29, 2019 | Jennifer Soup

GRx+Biosims: Back + Better Than Ever

Oct 22, 2019 | Erica Klinger

Associate Member Operation Smile: A Catalyst for Increasing Access to Safe Surgery

Oct 7, 2019 | Erica Klinger

A Positive Impact: How Our Members Show They Care

Oct 3, 2019 | Jennifer Soup

GRx+Biosims Spotlight: The Exposition

Sep 26, 2019 | Craig Burton

Three Recommendations to Save Money for Seniors and Taxpayers by Updating Medicare Part D